📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Topical application of a BCL-2 inhibitor ameliorates imiquimod-induced psoriasiform dermatitis by eliminating senescent cells. (2024)

First Author: Zhu H

Attributed to: Modulating Metabolic Programming of Memory B cell Activation to Restore B-cell Homeostasis in Autoimmune Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jdermsci.2024.06.002

PubMed Identifier: 38960840

Publication URI: http://europepmc.org/abstract/MED/38960840

Type: Journal Article/Review

Volume: 115

Parent Publication: Journal of dermatological science

Issue: 2

ISSN: 0923-1811